Endocrine system

Endocrine system

Metformin 500mg Tablet - Glucophage - 1 box

P06002295
Monotherapy or in combination with other oral antidiabetic agents or with insulin for type 2 DM in adults when dietary management & exercise alone does not result in adequate glycaemic control. In children >10 years & adolescents, may be used as monotherapy or in combination with insulin. Reduction of diabetic complications in overweight type 2...
Monotherapy or in combination with other oral antidiabetic agents or with insulin for type 2 DM in adults when dietary management & exercise alone does not result in adequate glycaemic control. In children >10 years & adolescents, may be used as monotherapy or in combination with insulin. Reduction of diabetic complications in overweight type 2...
Monotherapy or in combination with other oral antidiabetic agents or with insulin for type 2 DM in adults when dietary management & exercise alone does not result in adequate glycaemic control. In children >10 years & adolescents, may be used as monotherapy or in combination with insulin. Reduction of diabetic complications in overweight type 2...
Monotherapy or in combination with other oral antidiabetic agents or with insulin for type 2 DM in adults when dietary management & exercise alone does not result in adequate glycaemic control. In children >10 years & adolescents, may be used as monotherapy or in combination with insulin. Reduction of diabetic complications in overweight type 2...
Monotherapy or in combination with other oral antidiabetic agents or with insulin for type 2 DM in adults when dietary management & exercise alone does not result in adequate glycaemic control. In children >10 years & adolescents, may be used as monotherapy or in combination with insulin. Reduction of diabetic complications in overweight type 2...
Monotherapy or in combination with other oral antidiabetic agents or with insulin for type 2 DM in adults when dietary management & exercise alone does not result in adequate glycaemic control. In children >10 years & adolescents, may be used as monotherapy or in combination with insulin. Reduction of diabetic complications in overweight type 2...
Endocrine system

Metformin 500mg Tablet - Glucoxit - 1 strip

P06001898
Monotherapy or in combination with other oral antidiabetic agents or with insulin for type 2 DM in adults when dietary management & exercise alone does not result in adequate glycaemic control. In children >10 years & adolescents, may be used as monotherapy or in combination with insulin. Reduction of diabetic complications in overweight type 2...
Reduction in risk or delay of onset of type 2 DM in adults, overweight patients with impaired glucose & fasting tolerance and/or increased HbA1c who are at high risk for developing overweight type 2 DM & still progressing towards type 2 DM despite implementing intensive lifestyle change for 3-6 months. Monotherapy or in combination with other oral...
Reduction in risk or delay of onset of type 2 DM in adults, overweight patients with impaired glucose & fasting tolerance and/or increased HbA1c who are at high risk for developing overweight type 2 DM & still progressing towards type 2 DM despite implementing intensive lifestyle change for 3-6 months. Monotherapy or in combination with other oral...
Reduction in risk or delay of onset of type 2 DM in adults, overweight patients with impaired glucose & fasting tolerance &/or increased HbA1c who are at high risk for developing overweight type 2 DM & still progressing towards type 2 DM despite implementing intensive lifestyle change for 3-6 months.  Monotherapy or in combination with other...
Endocrine system

Metformin 500mg Tablet - Glumet XR

P06002314
Monotherapy or in combination with other oral antidiabetic agents or with insulin for type 2 DM in adults when dietary management & exercise alone does not result in adequate glycaemic control.  In children >10 years & adolescents, may be used as monotherapy or in combination with insulin. Reduction of diabetic complications in overweight type...
Initial therapy in type 2 DM when diet & exercise do not provide adequate glycemic control. Adjunct to diet & exercise to improve glycemic control in type 2 DM inadequately controlled on metformin or sitagliptin alone, or combination sitagliptin & metformin, or triple combination sitagliptin, metformin or sulfonylurea, or max tolerated dose of...
Initial therapy in type 2 DM when diet & exercise do not provide adequate glycemic control. Adjunct to diet & exercise to improve glycemic control in type 2 DM inadequately controlled on metformin or sitagliptin alone, or combination sitagliptin & metformin, or triple combination sitagliptin, metformin or sulfonylurea, or max tolerated dose of...
Initial therapy in type 2 DM when diet & exercise do not provide adequate glycemic control. Adjunct to diet & exercise to improve glycemic control in type 2 DM inadequately controlled on metformin or sitagliptin alone, or combination sitagliptin & metformin, or triple combination sitagliptin, metformin or sulfonylurea, or max tolerated dose of...
Initial therapy in type 2 DM when diet & exercise do not provide adequate glycemic control. Adjunct to diet & exercise to improve glycemic control in type 2 DM inadequately controlled on metformin or sitagliptin alone, or combination sitagliptin & metformin, or triple combination with sulfonylurea, or max tolerated dose of metformin &...
Initial therapy in type 2 DM when diet & exercise do not provide adequate glycemic control. Adjunct to diet & exercise to improve glycemic control in type 2 DM inadequately controlled on metformin or sitagliptin alone, or combination sitagliptin & metformin, or triple combination with sulfonylurea, or max tolerated dose of metformin &...
Initial therapy in type 2 DM when diet & exercise do not provide adequate glycemic control. Adjunct to diet & exercise to improve glycemic control in type 2 DM inadequately controlled on metformin or sitagliptin alone, or combination sitagliptin & metformin, or triple combination with sulfonylurea, or max tolerated dose of metformin &...
Type 2 DM as monotherapy in adults inadequately controlled by diet & exercise alone & for whom metformin is inappropriate due to intolerance. Add-on combination therapy with other glucose-lowering drugs eg, insulin & when diet & exercise is inappropriate. Reduction of CV death risks in patients with type 2 DM & established CV disease.
Type 2 DM as monotherapy in adults inadequately controlled by diet & exercise alone & for whom metformin is inappropriate due to intolerance. Add-on combination therapy with other glucose-lowering drugs eg, insulin & when diet & exercise is inappropriate. Reduction of CV death risks in patients with type 2 DM & established CV disease.
Type 2 DM as monotherapy in adults inadequately controlled by diet & exercise alone & for whom metformin is inappropriate due to intolerance. Add-on combination therapy with other glucose-lowering drugs eg, insulin & when diet & exercise is inappropriate. Reduction of CV death risks in patients w/ type 2 DM & established CV disease.
Product added to wishlist
Product added to compare.

This site uses cookies to personalize your experience, analyze site traffic and keeps track of items stored in your shopping basket.

By clicking ACCEPT or continuing to browse the site, you are agreeing to our use of cookies. See our Privacy Policy here for more details